Nexalin Technology Inc. (NXL)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.93M
Last updated: Nov 17, 2026 at 4:30 PM ET
Nexalin Technology Inc. (NXL) Valuation Multiples
Nexalin Technology (NXL) trades at 4.2x sales and 4.5x book value. Its P/B of 4.5x is below its 5-year median of 71.0x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 4.2x |
| Price to book | 4.5x |
| PEG | N/A |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 4.5x | 71.0x | N/A |
Valuation History
Over the 3 of the 4 year ends shown that have a P/S, its P/S ranged from 36.7x in 2023 to 253.0x in 2024.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $16.76 | N/A | 83.3x |
| 2024 | $82.88 | 253.0x | 207.8x |
| 2023 | $12.16 | 36.7x | 0.9x |
| 2022 | $22.49 | 102.7x | 29.9x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
GNG Quant
GNG Quant is GNG's own quant model: 25 measures in eight pillars, with the options pillar not yet in use. Every night it ranks each measure it has for Nexalin Technology Inc. against every stock GNG covers, and weighs the seven active pillar scores, some far more than others, into one composite score and a rating from Strong Buy to Strong Sell.
GNG Quant scores are part of GNG Pro. See plans
Scores run from 0 to 100 on every pillar, and higher is better on each: a cheaper valuation, faster growth and wider margins all score higher. The model also ranks each stock within its sector; the scores shown here are against every stock GNG covers. A pillar the stock has no data for is marked No data, and the composite counts it as neutral.
The rating comes from where the composite score ranks across the universe: the top 10% rate Strong Buy, the next 15% Buy, the middle 35% Hold, the next 20% Sell and the bottom 20% Strong Sell. When the market turns risk-off, the model leans harder on profitability and valuation and less on momentum and revisions.
| Pillar | What it measures | Measures |
|---|---|---|
| Valuation | Trailing P/E, EV/EBITDA, price to sales and free cash flow yield, where cheaper scores higher. | 4 |
| Growth | Revenue and earnings per share growth over three years, and revenue growth over the last year. | 3 |
| Profitability | Gross, operating and net margins, return on equity and return on invested capital. | 5 |
| Momentum | Returns over 12, 6 and 3 months that leave out the latest month, volatility-adjusted momentum and distance from the 52-week high. | 5 |
| Revisions | The change in the average earnings per share estimate over the last 90 days (60 or 30 days when that is all there is) and the average earnings surprise over the last four quarters. | 2 |
| Technical | Price against the 200-day average, the slope of the moving-average trend, 55-day breakouts and the 14-day RSI. | 4 |
| Sentiment | The tone of recent news about the company. | 1 |
| Options | The put to call open interest ratio, where fewer puts score higher. Not in use yet: no stock has this data. | 1 |
Frequently Asked Questions About NXL
Is NXL stock overvalued?
GNG's valuation label for NXL is Fairly valued.
What goes into the GNG Quant rating for NXL?
GNG Quant ranks Nexalin Technology on up to 24 measures in seven pillars (valuation, growth, profitability, momentum, revisions, technical and sentiment) against every stock GNG covers, and weighs the pillar scores, some far more than others, into one composite score. Its eighth pillar, options, has no data yet and does not count. The rating follows where that score ranks: the top 10% rate Strong Buy, the next 15% Buy, the middle 35% Hold, the next 20% Sell and the bottom 20% Strong Sell.
What is NXL's price to sales ratio?
Nexalin Technology has a price to sales ratio of 4.2x.
NXL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors